SecBot SecBot
COURT-RULING ·Filed Mar 2, 2026

KR

KROGER CO
NEUTRAL
Impact 4/10
Horizonmonths Processed5mo ago CourtCourt Ruling · courtlistener.com
Court ruling (district)
Actionable Insight • Neutral

The ruling is a procedural win for Kroger, its claims survive dismissal, but no damages have been quantified and the case is years from resolution. Monitor for summary judgment motions and any settlement discussions. The MDL's scope (scores of drugs, dozens of defendants) means Kroger's ultimate recovery, if any, is highly uncertain and likely years away.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$67.82
T+0 close · Mar 3, 2026 · via day close
Latest settled
−6.77%
T+60 · $63.23
Vs SPY
−17.99%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 3 $67.82entry
  2. T+1 · 9mo ago −0.95%α −1.65% · $67.17
  3. T+5 · 8mo ago +5.24%α +5.71% · $71.37
  4. T+20 · 8mo ago +5.42%α +9.57% · $71.49
  5. T+60 · 6mo ago −6.77%α −17.99% · $63.23
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

In the Generic Pharmaceuticals MDL, Judge Rufe partially granted and partially denied Epic Pharma's motions to dismiss antitrust claims. The Kroger Co. is among the eight plaintiffs whose complaints against Epic were found to sufficiently allege a conspiracy to fix prices of Ursodiol, those claims survive. Three other complaints (CVS, HCSC, Molina) were dismissed against Epic for insufficient pleading. For Kroger, the ruling removes near-term dismissal risk and allows the case to proceed toward discovery, but no damages have been awarded and the litigation remains in early stages.

Court Ruling Details

Ruling Date
Feb 27, 2026
Court
United States District Court for the Eastern District of Pennsylvania
Court Level
District
Judge
Cynthia M. Rufe
Case Type
antitrust
Ruling Type
motion to dismiss
Outcome
PARTIAL: mixed ruling, some claims won/lost
Precedent Risk
LOW

Key Facts

  • Kroger's complaint against Epic Pharma for Ursodiol price-fixing conspiracy survives Epic's motion to dismiss
  • The court found Kroger's complaint sufficiently alleged parallel conduct, motive, action against self-interest, and traditional conspiracy (meetings/communications between Epic, Lannett, and Actavis)
  • Epic raised Ursodiol price >1000% (from $0.45 to $5.10 per 300-mg unit) on May 6, 2014, days after Lannett entered at $5.11
  • Three other complaints (CVS, HCSC, Molina) were dismissed against Epic for failing to allege specific Epic conduct
  • No damages have been awarded, this is a motion-to-dismiss ruling, not a final judgment
  • The ruling is interlocutory; Epic may seek summary judgment after discovery

Financial Impact

No damages awarded or pleaded amount stated in the opinion. The ruling allows Kroger's antitrust claims against Epic to proceed, preserving potential recovery but with no quantified exposure or award at this stage.

legal_exposurelitigation_uncertainty

Risk Factors

  • Epic may move for summary judgment after discovery, potentially narrowing or eliminating claims
  • No damages have been awarded or quantified, ultimate recovery is uncertain
  • Appeals of interlocutory rulings are not immediately available, but final judgment appeals could take 1-2 additional years
  • The MDL has been ongoing since 2016; resolution timeline is extended

Market Snapshot

Exchange
NYSE
Sector
Retail-Grocery Stores
Analyst Consensus
58% bullish (33 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-1as9hv5f-KR

Track record

26 reports on KR

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +18.96% at T+60 after the May 19, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 4/10 Entry price pending
  2. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $65.02 Now $70.67 +8.69% settles Nov 25
  3. Oct 23, 202624d ago Institutional Cluster Neutral 3/10 Entry $66.77 Now $70.67 +5.84% settles Nov 20
  4. Oct 20, 202627d ago 8-K Neutral 5/10 Entry $62.98 Now $70.67 +12.21% settles Nov 17
  5. Oct 5, 20266w ago 8-K Neutral 3/10 Entry $58.78 to $66.76 Now $70.67 +20.23% ▲ +13.58% +16.04% vs SPY
  6. Sep 30, 20266w ago Court Ruling Neutral 3/10 Entry $59.48 to $65.93 Now $70.67 +18.81% ▲ +10.84% +10.14% vs SPY
  7. Sep 28, 20267w ago 424B5 Neutral 3/10 Entry $59.69 to $66.77 Now $70.67 +18.40% ▲ +11.86% +11.89% vs SPY
  8. Sep 25, 20267w ago Press Release Neutral 2/10 Entry $58.74 to $66.77 Now $70.67 +20.31% ▲ +13.67% +15.15% vs SPY
  9. Sep 17, 20268w ago Press Release Neutral 2/10 Entry $60.00 to $63.63 Now $70.67 +17.78% ▲ +6.05% +5.85% vs SPY
  10. Sep 11, 20269w ago 8-K Mixed 5/10 Entry $58.49 to $61.64 Now $70.67 +20.82% ▲ +5.39% +3.52% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (11h 44m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published Jun 6, 2026